NeuBase Therapeutics

YTD

ALL

Why Robinhood?

You can watch NBSE and buy or sell other stocks, ETFs, and their options commission-free!

About NBSE

NeuBase Therapeutics is a pre-clinical stage biopharmaceutical company that develops gene silencing therapies with its synthetic antisense oligonucleotides. It also provides a platform that focuses on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy, and Familial Parkinson's Disease, among others.

CEO

Todd P. Branning, MBA, CPA

CEOTodd P. Branning, MBA, CPA

Employees

—

Employees—

Headquarters

Pittsburgh, Pennsylvania

HeadquartersPittsburgh, Pennsylvania

Founded

2009

Founded2009

Employees

—

Employees—

NBSE Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.45

52 Week high$0.45

52 Week low

$0.36

52 Week low$0.36

People also own

Based on the portfolios of people who own NBSE. This list is generated using Robinhood data, and it’s not a recommendation.